NEWS RELEASE June 6, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC APPROVES MULTIPLE VIOLATION PENALTY SYSTEM A new penalty system for North American racing designed to reduce positive drug tests and identify and penalize trainers with multiple medication infractions took a major step toward implementation this week when the Racing Medication and Testing Consortium
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association
NEWS RELEASE January 25, 2013 Contact: Hallie Lewis (859) 224-2848 RMTC REPORTS OVERALL DECREASE IN PHENYLBUTAZONE VIOLATIONS IN JURISDICTIONS THAT ADOPTED 2 MICROGRAM THRESHOLD A recent Racing Medication and Testing Consortium (RMTC) review of violation records from nine states that lowered their phenylbutazone threshold from 5 micograms per milliliter of plasma to the RMTC-recommended level
NEWS RELEASE December 20, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD ANNOUNCES CORTICOSTEROID WITHDRAWAL RECOMMENDATIONS RESULTING FROM ITS CORTICOSTEROID EXPERTS CONFERENCE The Racing Medication and Testing Consortium (RMTC) recently approved minimum withdrawal time recommendations for corticosteroids. These recommendations were based on recently completed work funded in-part by RMTC and conducted at the University of
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE August 30, 2012 Contact: Hallie Lewis (859) 224-2848 STATEMENT FROM THE RACING MEDICATION AND TESTING CONSORTIUM The Kentucky Horse Racing Commission recently approved regulations based on the Association of Racing Commissioners International (RCI) Model Rules. The regulations concern major medications reported to the public in racing forms. These model rules, which incorporated broad
NEWS RELEASE July 11, 2012 Contact: Hallie Lewis (859) 224-2848 DR. DIONNE BENSON NAMED RMTC EXECUTIVE DIRECTOR AND COO The Racing Medication and Testing Consortium (RMTC) today announced the hiring of Dr. Dionne Benson as RMTC Executive Director and Chief Operating Officer. In her new position, which she assumed on Monday, Dr. Benson will provide
NEWS RELEASE April 24, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD NAMES INTERIM EXECUTIVE DIRECTOR, RECEIVES UPDATES ON DRUG ADMINISTRATION STUDIES AND MAKES THRESHOLD LEVEL RECOMMENDATION At its April 23 meeting in Dallas, Texas, the Racing Medication and Testing Consortium (RMTC) board of directors approved an agreement with The Jockey Club to engage the
NEWS RELEASE October 10, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (410) 392-9200 RACE DAY MEDICATION, DRUG TESTING INITIATIVES AND RESEARCH COMMITTEES PROVIDE UPDATES TO RMTC BOARD At its October 6 meeting in Scottsdale, Arizona, the Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from the race day medication,
NEWS RELEASE August 4, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (302) 981-6145 RMTC APPROVES NEW POLICY RECOMMENDATIONS BASED ON REPORTS FROM ITS RACE DAY MEDICATION COMMITTEES HEBRON, KY --The Racing Medication and Testing Consortium (RMTC) board of directors voted today to support a requirement that furosemide only be administered on race day
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
